Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0358420090520020228
Korean Journal of Obstetrics and Gynecology
2009 Volume.52 No. 2 p.228 ~ p.236
The clinicopathological relationship of E2F-1 and Ki-67 expression in endometrial cancer
Chong Hye-In

Baek Yun-Ji
Jang Ho-Jin
Suh Dong-Soo
Yoon Man-Soo
Choi Kyung-Un
Abstract
Objective: The aim of this study was to evaluate the correlation of E2F-1 and Ki-67 expression with clinicopathological prognostic factors.

Methods: Retrospectively, endometrial cancer slide samples (n=71) were analyzed. E2F-1 and Ki-67 were evaluated using immunohistochemical staining. And as a control (n=21), endometrial tissues were obtained by hysterectomy with benign gynecologic disease.

Results: Of 71 cases, the positive E2F-1 expression was 53.5% (38/71) in endometrial cancer. The expression of E2F-1 showed a remarkable positive correlation with myometrial invasion (P=0.001) and lymphovascular invasion (P=0.000). The Ki-67 labeling index was 30.56¡¾25.67 in endometrial cancer and 9.38¡¾8.35 in normal endometrial tissues (P=0.001). The Ki-67 labeling index showed positive correlations with increased tumor size (P=0.046, ¥ã=0.238), positive lymph node metastasis (P=0.001, ¥ã=0.396), cervical invasion (P=0.000, ¥ã=0.404) and lymphovascular tumor invasion (P=0.000, ¥ã=0.597). There was a positive correlation between E2F-1 and Ki-67 expression (P=0.000, ¥ã=0.734).

Conclusion: The Ki-67 expression seems to be related with tumor invasiveness and growth in endometrial cancer and shows a remarkable positive correlation with E2F-1. The E2F-1 expression seems to be not related as a direct prognostic factor but related with tumor invasiveness and growth in endometrial cancer.
KEYWORD
Endometrial cancer, E2F-1, Ki-67
FullTexts / Linksout information
  
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø